{"id":13665,"date":"2007-11-15T00:00:00","date_gmt":"2007-11-15T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/m004gmtg417\/"},"modified":"2019-03-01T15:04:29","modified_gmt":"2019-03-01T15:04:29","slug":"m004gmtg417","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/","title":{"rendered":"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs)"},"content":{"rendered":"<p>  <b>Featured Conference<\/b> <\/p>\n<p>    <b>4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs)<\/b><br \/>   <b>November 15 &#8211; 16, 2007 * Vienna, VA<\/b> <\/p>\n<p> <b>For more information or to register, please visit the <a href=\"http:\/\/www.cbinet.com\/show_conference.cfm?confCode=HB778\">conference website<\/a>.<\/b> <\/p>\n<\/p>\n<p class=\"MsoNormal\">Key Opinion Leaders (KOLs) continue to be crucial to the success in developing and marketing pharmaceutical products.\u00a0 However, there continues to be a disconnect in developing a company wide strategy for working with KOLs.\u00a0 CBI\u2019s 4th Annual Forum provides a unique platform for clinical, medical affairs, MSLs, marketing and also academic institutions to interact and discuss strategies for successful collaboration with KOLs throughout the product lifecycle.\u00a0 Attend this conference and learn processes, communication strategies and guidelines for effective interactions with KOLs.<\/p>\n<p class=\"MsoNormal\">Key topics being research for the 2007 forum include:<\/p>\n<ul>\n<li>KOL Professional development needs<\/li>\n<li>Identifying up and coming KOLs<\/li>\n<li>Differentiating and separating Opinion Leaders and Key Opinion Leaders<\/li>\n<li>Defining a company\u2019s need and objective for a KOL<\/li>\n<li>KOL compliance<\/li>\n<li>Regional monitoring of KOLs<\/li>\n<\/ul>\n<p><\/p>\n<p> <strong>Hear what some of our previous attendees had to say:<\/strong><\/p>\n<\/p>\n<p class=\"MsoNormal\">\u201cA great deal of insight that can be readily applied to my organization\u2019s day to day practice.\u201d<br \/>  \u2013\u00a0 <i>Sheela Gallard, Associate Director Medical Science,<\/i>\u00a0<b>Organon<\/b><\/p>\n<p>\u201cThe conference brought together industry professionals from various disciplines to share experiences, ideas and solutions for KOL identification, management and optimization.\u201d<br \/> \u2013 <i>Louis Hudspeth, Ph.D., Regional Director, Department of Scientific Affairs, Central U.S.,<\/i>\u00a0<b>Berlex Oncology<\/b><\/p>\n<p>       For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com or <b>visit the <a href=\"http:\/\/www.cbinet.com\/show_conference.cfm?confCode=HB778\">conference website<\/a>.<\/b>       <\/p>\n<p>  <a href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/pm-mtgs.html\"><i>Return to list of conferences&#8230;<\/i><\/a> <\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This Annual Forum provides a unique platform for clinical, medical affairs, MSLs, marketing and also academic institutions to interact and discuss strategies for successful collaboration with KOLs throughout the product lifecycle.<\/p>\n","protected":false},"author":2,"featured_media":13101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1203],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"This Annual Forum provides a unique platform for clinical, medical affairs, MSLs, marketing and also academic institutions to interact and discuss strategies for successful collaboration with KOLs throughout the product lifecycle.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2007-11-15T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-03-01T15:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"744\" \/>\n\t<meta property=\"og:image:height\" content=\"419\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/\",\"url\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/\",\"name\":\"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2007-11-15T00:00:00+00:00\",\"dateModified\":\"2019-03-01T15:04:29+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs)\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/","og_locale":"en_US","og_type":"article","og_title":"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) - Pharma Marketing Network","og_description":"This Annual Forum provides a unique platform for clinical, medical affairs, MSLs, marketing and also academic institutions to interact and discuss strategies for successful collaboration with KOLs throughout the product lifecycle.","og_url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/","og_site_name":"Pharma Marketing Network","article_published_time":"2007-11-15T00:00:00+00:00","article_modified_time":"2019-03-01T15:04:29+00:00","og_image":[{"width":744,"height":419,"url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/03\/pmn-logo-intro-post-1.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/","url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/","name":"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2007-11-15T00:00:00+00:00","dateModified":"2019-03-01T15:04:29+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/meetings\/m004gmtg417\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"4th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs)"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13665"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=13665"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13665\/revisions"}],"predecessor-version":[{"id":13894,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/13665\/revisions\/13894"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/13101"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=13665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=13665"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=13665"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=13665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}